HCA Holdings Inc. buy Royal Bank of Canada
Start price
25.10.23
/
50%
€213.30
Target price
25.10.24
€268.66
Performance (%)
69.42%
Price
04.10.24
€359.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for HCA Holdings Inc. has seen massive gains of 69.42%. Dividends of €2.37 are taken into consideration when calculating the performance. This prediction currently runs until 25.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
HCA Holdings Inc. | -0.664% | -0.664% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank of Canada from $315.00 to $284.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for HCA Holdings Inc.
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€347.20
23.08.24
23.08.24
€361.87
23.08.25
23.08.25
3.57%
04.10.24
04.10.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€314.80
24.07.24
24.07.24
€348.18
24.07.25
24.07.25
14.23%
04.10.24
04.10.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€290.50
29.04.24
29.04.24
€307.19
29.04.25
29.04.25
24.00%
04.10.24
04.10.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€282.20
31.01.24
31.01.24
€296.76
31.01.25
31.01.25
27.86%
04.10.24
04.10.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€244.70
13.09.23
13.09.23
€293.45
13.09.24
13.09.24
47.21%
14.09.24
14.09.24